ArticleFrontiers in pharmacology2024

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND).

Stav Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.